Itâs not easy being a wearable hardware startup. Itâs also hard being an impact health tech startup. Now, a wearable health tech startup dedicated to fighting diabetes? Thatâs like diving through a flaming hoop, blindfolded.
But to Harry Gandhi, CEO and co-Founder of Medella Health, which is building a contact lens to non-invaseivly monitor and transmit blood glucose levels to a mobile device, that flaming hoop represents a window of opportunity.
âIf you were to ask me five years ago to build something like this, it would not be possible.â
âIf you were to ask me five years ago to build something like this, it would not be possible,â Gandhi told BetaKit in this audio interview. “But if you asked us to build something like this five years from now, it would be too late because thereâd be so many players in the space.”
A member of the University of Waterlooâs Velocity program (in its new Foundry division), Gandhi also feels that Medella is uniquely positioned to take advantage of this window of opportunity. Gandhi told us that the Kitchener-Waterloo region provides close proximity to the advanced nanotechnology and contact lens research institutions required to make Medellaâs solution work.
âAll this coming together in one place is whatâs allowed us to build technology like this, and it doesnât exist in many other places around the world. Youâd be hard pressed to find another place that has all these elements together,â he said.
Of course, as a health tech startup, Medella faces many regulatory and clinical hurdles unknown to most hardware startups. Whatâs worse is a Canadian healthcare system that, while not adverse to new technology, is mired in an operational structure that hasnât altered much over the past 50 years. Not to mention a funding climate that is still tentative towards impact investment.
Gandhiâs solution is a mixture of patience and extreme focus.
âOftentimes we learned that scientists and engineers build a fantastic solution and then they try to find a problem, rather than the other way around. Thatâs not the pitfall we wanted to go down.”